The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Santamaria Babi, L. F.
Right arrow Articles by Hauser, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Santamaria Babi, L. F.
Right arrow Articles by Hauser, C.

The Journal of Immunology, Vol 154, Issue 4 1543-1550, Copyright © 1995 by American Association of Immunologists


ARTICLES

Migration of skin-homing T cells across cytokine-activated human endothelial cell layers involves interaction of the cutaneous lymphocyte-associated antigen (CLA), the very late antigen-4 (VLA-4), and the lymphocyte function-associated antigen-1 (LFA-1)

LF Santamaria Babi, R Moser, MT Perez Soler, LJ Picker, K Blaser and C Hauser
Swiss Institute of Allergy and Asthma Research, Davos.

The cutaneous lymphocyte-associated Ag (CLA) is expressed by a subset of circulating memory/effector T cells and by the vast majority of skin- infiltrating T cells. CLA is thought to target skin-associated T cells to inflammatory skin sites by interacting with endothelial cell ligand E-selectin (CD62E). We have examined adhesion molecules involved in the migration of human CLA+ and CLA- memory/effector T lymphocytes through IL-1- and TNF-alpha-activated and nonactivated HUVEC layers under static (nonflow) conditions. CLA-enriched memory/effector T lymphocytes migrated more actively across cytokine-activated HUVEC than CLA- depleted memory/effector T cells. This enhanced migration is dependent on the CLA/E-selectin interaction. mAb to very late Ag-4 (VLA-4) and vascular cell adhesion molecule-1 (VCAM-1) blocked the migration of CLA- enriched, but not of CLA-depleted, T cells across activated HUVEC. The observation that anti-VLA-4 and anti-CLA mAb did not show additional inhibition supports the concept that CLA and VLA-4 are sequentially involved in the extravasation. The fact that only CLA+ T cells were inhibited by the anti-VLA-4 mAb suggests that, in this system, CLA engagement is required for using the VLA-4/VCAM-1 pathway. Our studies demonstrate that CLA+ T cells use LFA-1/intercellular leukocyte adhesion molecule-1 (ICAM-1) for transmigration but that CLA expression is not required for the LFA-1/ICAM-1-dependent transmigration because anti-CD18/CD11a mAbs and anti-ICAM-1 mAbs were able to block T cell migration regardless of the activation state of HUVEC or the CLA expression by T cells. Taken together, our results suggest that CLA has a homing function in conducting the T cell to interact with LFA-1/ICAM- 1 and/or VLA-4/VCAM-1; this results in enhanced adhesion and migration across cytokine-activated endothelial cells.


This article has been cited by other articles:


Home page
BloodHome page
K. Ohmori, F. Fukui, M. Kiso, T. Imai, O. Yoshie, H. Hasegawa, K. Matsushima, and R. Kannagi
Identification of cutaneous lymphocyte-associated antigen as sialyl 6-sulfo Lewis X, a selectin ligand expressed on a subset of skin-homing helper memory T cells
Blood, April 15, 2006; 107(8): 3197 - 3204.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Jones, S. Ibrahim, K. Patel, R. Luthra, M. Duvic, and L. J. Medeiros
Degree of CD25 Expression in T-Cell Lymphoma Is Dependent on Tissue Site: Implications for Targeted Therapy
Clin. Cancer Res., August 15, 2004; 10(16): 5587 - 5594.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Q. Wu, Y.-X. Fu, and R. D. Sontheimer
Blockade of Lymphotoxin Signaling Inhibits the Clinical Expression of Murine Graft-versus-Host Skin Disease
J. Immunol., February 1, 2004; 172(3): 1630 - 1636.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Bajenoff and S. Guerder
Homing to Nonlymphoid Tissues Is Not Necessary for Effector Th1 Cell Differentiation
J. Immunol., December 15, 2003; 171(12): 6355 - 6362.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Hudak, M. Hagen, Y. Liu, D. Catron, E. Oldham, L. M. McEvoy, and E. P. Bowman
Immune Surveillance and Effector Functions of CCR10+ Skin Homing T Cells
J. Immunol., August 1, 2002; 169(3): 1189 - 1196.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
Z. Ding, K. Xiong, and T. B. Issekutz
Chemokines stimulate human T lymphocyte transendothelial migration to utilize VLA-4 in addition to LFA-1
J. Leukoc. Biol., March 1, 2001; 69(3): 458 - 466.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
R. Mortarini, A. Borri, G. Tragni, I. Bersani, C. Vegetti, E. Bajetta, S. Pilotti, V. Cerundolo, and A. Anichini
Peripheral Burst of Tumor-specific Cytotoxic T Lymphocytes and Infiltration of Metastatic Lesions by Memory CD8+ T Cells in Melanoma Patients Receiving Interleukin 12
Cancer Res., July 1, 2000; 60(13): 3559 - 3568.
[Abstract] [Full Text]


Home page
J. Exp. Med.Home page
T. Nishimura, K. Iwakabe, M. Sekimoto, Y. Ohmi, T. Yahata, M. Nakui, T. Sato, S. Habu, H. Tashiro, M. Sato, et al.
Distinct Role of Antigen-specific T Helper Type 1 (Th1) and Th2 Cells in Tumor Eradication In Vivo
J. Exp. Med., September 6, 1999; 190(5): 617 - 628.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Akdis, H.-U. Simon, L. Weigl, O. Kreyden, K. Blaser, and C. A. Akdis
Skin Homing (Cutaneous Lymphocyte-Associated Antigen-Positive) CD8+ T Cells Respond to Superantigen and Contribute to Eosinophilia and IgE Production in Atopic Dermatitis
J. Immunol., July 1, 1999; 163(1): 466 - 475.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
J. Kehren, C. Desvignes, M. Krasteva, M.-T. Ducluzeau, O. Assossou, F. Horand, M. Hahne, D. Kagi, D. Kaiserlian, and J.-F. Nicolas
Cytotoxicity Is Mandatory for CD8+ T Cell-mediated Contact Hypersensitivity
J. Exp. Med., March 1, 1999; 189(5): 779 - 786.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. M. Marelli-Berg, L. Frasca, L. Weng, G. Lombardi, and R. I. Lechler
Antigen Recognition Influences Transendothelial Migration of CD4+ T Cells
J. Immunol., January 15, 1999; 162(2): 696 - 703.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Gerli, C. Paolucci, P. Gresele, O. Bistoni, S. Fiorucci, C. Muscat, S. Belia, A. Bertotto, and V. Costantini
Salicylates Inhibit Adhesion and Transmigration of T Lymphocytes by Preventing Integrin Activation Induced by Contact With Endothelial Cells
Blood, October 1, 1998; 92(7): 2389 - 2398.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. H. Orteu, L. W. Poulter, M. H. A. Rustin, C. A. Sabin, M. Salmon, and A. N. Akbar
The Role of Apoptosis in the Resolution of T Cell-Mediated Cutaneous Inflammation
J. Immunol., August 15, 1998; 161(4): 1619 - 1629.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.